Eriksson, B., & Feuring, M. (2016). An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery. Thrombosis research, 144, . https://doi.org/10.1016/j.thromres.2016.06.017
Chicago-Zitierstil (17. Ausg.)Eriksson, Bengt, und Martin Feuring. "An Open-label Study of the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate 150mg Once Daily in Caucasian Patients with Moderate Renal Impairment Undergoing Primary Unilateral Elective Total Knee or Hip Replacement Surgery." Thrombosis Research 144 (2016). https://doi.org/10.1016/j.thromres.2016.06.017.
MLA-Zitierstil (9. Ausg.)Eriksson, Bengt, und Martin Feuring. "An Open-label Study of the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate 150mg Once Daily in Caucasian Patients with Moderate Renal Impairment Undergoing Primary Unilateral Elective Total Knee or Hip Replacement Surgery." Thrombosis Research, vol. 144, 2016, https://doi.org/10.1016/j.thromres.2016.06.017.